Zerga, M. (2025) “Bispecific antibodies in the treatment of relapsed/refractory diffuse large B cell lymphoma. Role of epcoritamab”, Journal of Hematology, 29(1), pp. 11–21. doi: 10.48057/hematologa.v29i1.639.